Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a 10% revenue decline and a 15% drop in net income, primarily due to pricing pressures and increased raw material costs. Additionally, EBITDA and operating cash flow both decreased, indicating financial strain. The absence of positive strategic updates or shareholder return plans further dampens sentiment. While there are no explicit risks mentioned, the financial performance suggests challenges. Given these factors, a negative sentiment is appropriate, predicting a stock price movement between -2% to -8% over the next two weeks.
Revenue Westlake Corporation reported revenue of $3.5 billion for Q1 2026, a decrease of 10% year-over-year. The decline was attributed to lower sales volumes and pricing pressures in the Performance and Essential Materials segment.
Net Income Net income for Q1 2026 was $450 million, down 15% compared to the same period last year. This decrease was primarily due to higher raw material costs and reduced operating margins.
EBITDA The company achieved an EBITDA of $800 million in Q1 2026, representing a 12% decline year-over-year. The reduction was driven by weaker demand in the Housing and Infrastructure segment.
Operating Cash Flow Operating cash flow stood at $600 million for Q1 2026, a 5% decrease from the prior year. This was mainly due to increased working capital requirements.
Gross Margin Gross margin for Q1 2026 was 28%, down from 30% in the previous year. The decline was attributed to higher input costs and competitive pricing pressures.
The selected topic was not discussed during the call.
Market Conditions: The transcript does not explicitly mention any risks related to market conditions.
Competitive Pressures: The transcript does not explicitly mention any risks related to competitive pressures.
Regulatory Hurdles: The transcript does not explicitly mention any risks related to regulatory hurdles.
Supply Chain Disruptions: The transcript does not explicitly mention any risks related to supply chain disruptions.
Economic Uncertainties: The transcript does not explicitly mention any risks related to economic uncertainties.
Strategic Execution Risks: The transcript does not explicitly mention any risks related to strategic execution.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The earnings call reveals a 10% revenue decline and a 15% drop in net income, primarily due to pricing pressures and increased raw material costs. Additionally, EBITDA and operating cash flow both decreased, indicating financial strain. The absence of positive strategic updates or shareholder return plans further dampens sentiment. While there are no explicit risks mentioned, the financial performance suggests challenges. Given these factors, a negative sentiment is appropriate, predicting a stock price movement between -2% to -8% over the next two weeks.
The earnings call revealed mixed signals: strong financial metrics with a focus on cost savings and strategic acquisitions, but tempered by weak guidance and cautious market outlooks. The Q&A highlighted uncertainties, such as vague responses on free cash flow and tariff impacts, which prevent a strong positive sentiment. The lack of specific guidance and cautious tone, alongside structural cost savings and strategic investments, suggest a neutral short-term stock price movement.
The earnings report indicates strong financial performance with significant year-over-year growth in revenue, net income, and EBITDA. The Q&A reveals a robust pipeline for large-scale machines and potential in new markets, including alternative proteins and pharmaceuticals. Despite some uncertainties, the overall outlook is optimistic with plans for expansion and profitability targets. The company's strategic focus on new markets and potential breakeven achievements suggest a positive stock price movement over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.